期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | PHARMACOGENOMICS LetPub Score 5.2
50 ratings
Rate
Reputation 6.3 Influence 4.0 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | PHARMACOGENOMICS | ||||||||||||||||||||||||
ISSN | 1462-2416 | ||||||||||||||||||||||||
E-ISSN | 1744-8042 | ||||||||||||||||||||||||
h-index | 83 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 10.50%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.futuremedicine.com/loi/pgs | ||||||||||||||||||||||||
在線稿件提交 | http://www.futuremedicine.com/page/onlinesubmissions | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Future Medicine Ltd. | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 75每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 11.16% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1462-2416%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[PHARMACOGENOMICS] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:19:33 評論於 Additive effect refers to the effect of using two drugs together is equal to the effect of using double the dose of each drug individually. If the therapeutic effect obtained from the combination of two drugs is greater than the sum of the effects of the two drugs used individually, it is called a synergistic effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:37:05 評論於 4-6 pictures(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 23:10:36 評論於 How many figures/tables are usually required by regular journals?(0) 讚! | 修然小公主 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:23:47 評論於 What is synergy? What is additive effect? What is the difference between the two?(0) 讚! | 龙鳞孝礼 |
作者: 平原笑柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-12 21:44:39 評論於 Hello, is this an OA journal?(0) 讚! | 平原笑柳 |
作者: Alma Newton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-15 20:41:58 評論於 Review Speed: 1.0 Experience Sharing: Submitted at the end of November, first review took one month, revised for second review at the end of December, accepted in mid-May, published online in June. Editor was very kind, submission process took six months(0) 讚! | Alma Newton |
作者: 新瑶少女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-06 12:59:28 評論於 Review speed: 6.0 | Submission acceptance rate: 50.0 Focused research areas: Pharmacogenomics Experience sharing: Submitted on November 13, 2019, revised on February 13, 2020, revised again on May 23, 2020, accepted in July. Overall, it is acceptable. No publication fee or page charges(0) 讚! | 新瑶少女 |
作者: 奉天俊强 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-02-06 23:40:52 評論於 The journal has been downgraded to Tier 4 in the latest 2020 ranking by the Chinese Academy of Sciences(0) 讚! | 奉天俊强 |
作者: 奉天俊强 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-25 16:49:52 評論於 Published yesterday(0) 讚! | 奉天俊强 |
作者: 奉天俊强 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-12 21:48:29 評論於 I am working on a research-based original paper(0) 讚! | 奉天俊强 |
作者: Alma Newton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-06 17:11:58 評論於 Can this magazine only accept reviews? The style they accept for publication seems really strange(0) 讚! | Alma Newton |
作者: 奉天俊强 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-28 17:14:38 評論於 Review speed: 3.0 | Submission acceptance rate: 75.0 Experience sharing: Just received a submission, first review took about four months, minor revisions in the first round of feedback, accepted immediately after revision, still a very friendly journal(0) 讚! | 奉天俊强 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 19:17:57 評論於 The continuous decline, if it continues, will it break 2? In just one year, it has fallen quite a bit, even 0.1 point should be cherished(0) 讚! | 凌霄高洁 |
作者: Osborn Walpole 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-05-11 22:21:17 評論於 Review speed: 3.0 | Submission success rate: 25.0 Experience sharing: High language requirements, plagiarism check will be conducted(0) 讚! | Osborn Walpole |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-03-22 15:33:46 評論於 First review, over two months; second review, within one month; waiting for proof, four months. The editor-in-chief is very nice. The article needs to be very rigorous, including rigorous and meticulous verification of experiments and language wording(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 13:43:16 評論於 Focused research direction: Genomics(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-12-29 09:12:01 評論於 I have reviewed two articles for this magazine, both have been rejected(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us